Á¦135Â÷ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ : 2023-04-08
±³À°ÀÏÀÚ : 2023-04-08
±³À°Àå¼Ò : ¿©¼öÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ : Á¦135Â÷ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
´ã´çÀÚ : ±è¹Ì¼±
¿¬¶ôó : 02-575-3825
À̸ÞÀÏ : katrd@hanmail.net
±³À°Á¾·ù : ³»°úÀÇÇб³À°, ±âŸ
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 3Á¡ (ÀÏ¹Ý 2Á¡ / Çʼö 1Á¡)
Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ, ÀϹÝÀÇ 30,000¿ø / Àü°øÀÇ, ±âŸ 20,000¿ø ÇöÀåµî·Ï : Àü¹®ÀÇ, ÀϹÝÀÇ 40,000 / Àü°øÀÇ, ±âŸ 30,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 11:55~12:35 New Treatment Modalities for Patients with Chronic Bronchitis ÀÌÁø±¹(°¡Å縯ÀÇ´ë ³»°ú)
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 13:15~14:05 Clinical Applications of Single-Cell RNA Sequencing À±Á¤Çö(- Harvard Medical School Brigham and Women's Hospital)
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 14:05~14:35 ¿¬¸íÀÇ·á°áÁ¤Á¦µµÀÇ ÀÌÇØ¿Í ½ÇÁ¦ ÇãÁø¿ø(¿ï»êÀÇ´ë ³»°ú)
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 14:35~15:05 È£Èí±â¿Í °ü·ÃµÈ ÀÇ·áºÐÀï»ç·Ê °°æÈ£(Çѱ¹ÀÇ·áºÐÀïÁ¶Á¤ÁßÀç¿ø)
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 15:20~15:45 Oral Shorter Regimen for MDR-TB in Korea - 1.Pro °û³«¿ø(¼¿ïÀÇ´ë ³»°ú)
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 15:45~16:10 Oral Shorter Regimen for MDR-TB in Korea - 2.Con ±Ç¿ë¼ö(Àü³²ÀÇ´ë ³»°ú)
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 16:10~16:35 Is Combined Pulmonary Fibrosis and Emphysema (CPFE) a Distinct Entity? - 1.Pro ÃÖÇý¼÷(°æÈñÀÇ´ë ³»°ú)
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 16:35~17:00 Is Combined Pulmonary Fibrosis and Emphysema (CPFE) a Distinct Entity? - 2.Con ¾ç¼¼ÈÆ(¿ø±¤ÀÇ´ë ³»°ú)
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 17:15~17:40 NIV vs. HFNC for Acute Respiratory Failure: What Is Your Choice? - 1.Pro ±èÁ¤¼ö(ÀÎÇÏÀÇ´ë ³»°ú)
±³À°½Ã°£ 04-08 °ÀÇ½Ç A,B 17:40~18:05 NIV vs. HFNC for Acute Respiratory Failure: What Is Your Choice? - 2.Con À̼öȯ(¿¬¼¼ÀÇ´ë ³»°ú)